Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases-Reference-Cited by-同舟云学术

Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases

Published:2024-09-12 Issue:9 Volume:2024 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Schipper Sivan¹,Nigam Kabir²,Schmid Yasmin³,Piechotta Vanessa⁴,Ljuslin Michael⁵⁶⁷,Beaussant Yvan⁶⁷,Schwarzer Guido⁸,Boehlke Christopher⁹¹⁰

Affiliation:

1. Department of Medicine; Spital Uster; Uster Switzerland

2. Department of Psychiatry; Brigham and Women’s Hospital; Boston USA

3. Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research; University Hospital Basel and University of Basel; Basel Switzerland

4. Department for Infectious Disease Epidemiology; Robert Koch Institute; Berlin Germany

5. Palliative Medicine Division, Department of Rehabilitation and Geriatrics; Geneva University Hospitals; Geneva Switzerland

6. Department of Psychosocial Oncology and Palliative Care; Dana-Farber Cancer Institute; Boston USA

7. Harvard Medical School; Boston USA

8. Institute of Medical Biometry and Statistics; Faculty of Medicine and Medical Center, University of Freiburg; Freiburg Germany

9. Department of Clinical Research; University Hospital Basel and University of Basel; Basel Switzerland

10. Palliative Care Center Basel; Basel Switzerland

Publisher

Wiley

Reference185 articles.

1. Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases;Gasser;Journal of Nervous and Mental Disease,2014

2. Gasser P Cochrane PAT review [personal communication] Email to: C Boehlke

3. Lysergic acid diethylamide (LSD)-assisted psychotherapy in people with illness-related anxiety clinicaltrials.gov/study/NCT00920387

4. Griffith R A single dose of psilocybin produces substantial and enduring decreases in anxiety and depression in patients with a life-threatening cancer diagnosis: a randomized double-blind trial Neuropsychopharmacology 2015 S90 1 10.1038/npp.2015.324

5. Griffith R Cochrane meta-analyses for PAT in palliative care [personal communication] Email To: C Boehlke